Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • News & Developments
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • News & Developments
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Data Protection policies
  • Cookies Policy
  • Supplier Code of Conduct
  • Modern Slavery and Human Trafficking Statement
  • Contact Us
  • home
  • Market Intelligence
  • Search

2,093 results found

Use advanced search filters to refine your search

1 filter applied

Advanced search filters

Topics
Countries
Contributor
Content type
Show options
  • Article

    Whether IBC Empowers NCLT/NCLAT To Interfere In The Commercial Contracts Of The Corporate Debtor After Appointment Of IRP/RP?

    This article is based on the analysis of the case decided by the Hon'ble National Company Law Appellate Tribunal (NCLAT) in the matter of Tata Consultancy Services Limited v. Vishal Ghisulal Jain...
    IndiaCorporate/Commercial Law
    S&A Law Offices
    S&A Law Offices
  • Article

    Teachers Are Employees And Entitled To Claim Gratuity w.e.f. 03.04.1997: SC

    The Hon'ble Supreme Court recently reversed its own judgment dated 07.01.2019 in the matter of Birla Institute Technology vs. the State of Jharkhand & Ors. as per which teachers were denied the benefit of gratuity ...
    IndiaEmployment and HR
S&A Law Offices
S&A Law Offices
  • Article

    Waiver Of Cooling Period Under Sec 13B (2) Of Hindu Marriage Act, 1955

    In a recent decision of Amardeep Singh vs. Harveen Kaur, the apex court had a chance to interpret the law regarding mandatory ‘cooling off' period ...
    IndiaFamily and Matrimonial
    S&A Law Offices
    S&A Law Offices
  • Article

    Listing On Foreign Stock Exchanges: Looking Beyond Borders

    During the economic reforms of 1990s, drastic changes were made to the economy by adoption of the principles of liberalization, privatization and globalization.
    IndiaFinance and Banking
    S&A Law Offices
    S&A Law Offices
  • Article

    Loans & Advances By Banks To Their CEO/WTDS

    The Reserve Bank of India (RBI), vide circular DBR.Dir. BC.No.38/13.03.00/2015-16, dated September 16, 2015, allowed commercial banks to grant loans and advances to its Chief Executive Officer/ Whole Time Directors...
    IndiaFinance and Banking
    S&A Law Offices
    S&A Law Offices
  • Article

    Confusion Around The Status Of Electronic Nicotine Delivery Systems: Drug Or Poison?

    Variation in chemicals produce known and unknown toxicity which raises red flags about the safety and efficacy of this system.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    EMA Adopts ICH S9 Guideline On Non-Clinical Evaluation Of Anti-Cancer Pharmaceuticals

    On 16 May 2018, the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted the ICH S9 guideline on non-clinical evaluation of anti-cancer pharmaceuticals (Step 5) ...
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Fixation Of Prices Of Drugs Under The DPCO , 2013: Application Of Para 19 Only In Extra-Ordinary Circumstances

    Indian Pharmaceutical Industry is at present, at its most progressive era where it has witnessed a robust growth over the past few years.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    India Healthcare Highlights July 2019

    This segment of the newsletter shares recent information associated with regulatory reforms from Healthcare and Pharmaceutical sectors from in Indian jurisdiction.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Ministry Of Health (Moh) Releases 3 Draft Gazettes Seeking Amendments To Drug & Cosmetics Rules, 1945

    However, it is also proposed that the permit holder should submit the details of the drugs imported and utilized, to the licensing authorities on a yearly basis from the date specified.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Multiple Sclerosis (MS) Drug Daclizumab (Zinbryta) Withdrawn From The Market

    On March 02, 2018, pharmaceutical companies Biogen and AbbVie announced that they are voluntarily withdrawing Daclizumab for relapsing multiple sclerosis off the global markets...
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Osimertinib Granted Breakthrough Designation By FDA For 1st-line Treatment Of Patients With EGFR (Epidermal Growth Factor Receptor) Mutation-Positive Non-Small Cell Lung Cancer (NSCLC)

    Osimertinib targets this secondary mutation that leads to disease progression.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Post Marketing Surveillance Of Drugs

    Post marketing surveillance is performed after market approval/clinical trials of drugs in India.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    United States Food And Drug Administration Permits Marketing Of First Artificial Intelligence Based Device

    Diabetic retinopathy occurs when high levels of blood sugar lead to damage in the blood vessels of the retina, the light-sensitive tissues at the back of the eye.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    US FDA Highlights July 2019

    This segment discusses the recent drug approvals from the US FDA in various severe diseases. The write-ups describe the role of a new drug in the treatment of serious conditions such as myeloma
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    USFDA Approves Two New Treatments For Rare Blood Diseases

    The FDA also granted Breakthrough Therapy designation, Orphan Drug designation and Priority Review designation to Elzonris.
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Orders Under Insolvency And Bankruptcy Code, 2016 WRT Corporate Persons

    The Adjudicating Authority has the discretion to provide several opportunities for settlement of the debt
    IndiaInsolvency/Bankruptcy/Re-Structuring
    S&A Law Offices
    S&A Law Offices
  • Article

    False Information Furnished In An Application Under Section 7 Of The Insolvency And Bankruptcy Code, 2016

    The Insolvency and Bankruptcy Code 2016 (hereinafter referred to as ‘Code') attempts to consolidate the laws for insolvency resolution of corporate persons in a time bound manner.
    IndiaInsolvency/Bankruptcy/Re-Structuring
    S&A Law Offices
    S&A Law Offices
  • Article

    Insolvency Resolution Process: Who Is Authorized To Initiate?

    A question arises as to who can file application under the Code on behalf of the Companies or Corporate Persons as they are juristic entities.
    IndiaInsolvency/Bankruptcy/Re-Structuring
    S&A Law Offices
    S&A Law Offices
  • Article

    Insolvency Round Up - June 2022

    Filing of the list of stakeholders under clause (d) of sub-regulation (5) of regulation 31 of the Insolvency and Bankruptcy Board of India (Liquidation Process) Regulations, 2016
    IndiaInsolvency/Bankruptcy/Re-Structuring
    S&A Law Offices
    S&A Law Offices
  • Showing 701–720 of 2093 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics